mothers and fathers [1%:15 years: Refer to adult dosing. Dosing: Renal Impairment There are no dosage adjustments provided in the manufacturer s labeling. Dosing: Hepatic Impairment Use is contraindicated in patients with hepatic insufficiency. The following adjustments have been recommended for hepatotoxicity during treatment (Stock 2011): ALT/AST >3 to 5 times ULN: Continue therapy. ALT/AST >5 to 20 times ULN: Delay next dose until transaminases] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Asparaginase escherichia coli Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Drug Class Miscellaneous antineoplastics Related Drugs miscellaneous antineoplastics tretinoin , Revlimid , Zytiga , Accutane , isotretinoin , irinotecan Acute Lymphocytic Leukemia prednisone , methotrexate , Deltasone , cyclophosphamide , Cytoxan , vincristine , Trexall , Sterapred , daunorubicin , Prednicot , teniposide , asparaginase erwinia chrysanthemi , Sterapred DS , Oncovin , Erwinaze , Cytoxan Lyophilized , Elspar , More... may be
reading Asparaginase (E. coli) aggravating
EmoticonEmoticon